VRNA
Verona Pharma
VRNA • NASDAQ
Verona Pharma is a pharmaceutical preparations company trading on NASDAQ, led by CEO David S. Zaccardelli.
CEODavid S. Zaccardelli
Next Earnings
No upcoming earnings scheduled for Verona Pharma
No earnings announcement scheduled
Earnings History
Past 12 earnings reports for Verona Pharma
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 3, 2026 | Q3 2025 | —Est: $0.20 | — | —Est: $96.3M | — | — |
| Aug 6, 2025 | Q2 2025 | $0.13Est: $0.06 | +116.7% | $103.1MEst: $77.3M | +33.5% |  10-Q |
| Apr 29, 2025 | Q1 2025 | -$0.16Est: -$0.22 | +27.3% | $76.3MEst: $48.7M | +56.5% | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.40Est: -$0.23 | -73.9% | $36.7MEst: $36.1M | +1.6% | 10-K |
| Nov 4, 2024 | Q3 2024 | -$0.53Est: -$0.50 | -6.0% | $5.6MEst: $2.0M | +179.8% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.80Est: -$0.29 | -175.9% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.32Est: -$0.16 | -100.0% | - | — | 10-Q |
| Feb 29, 2024 | Q4 2023 | -$0.18Est: -$0.26 | +30.8% | -Est: - | — | 10-K |
| Nov 2, 2023 | Q3 2023 | -$0.16Est: -$0.28 | +42.9% | - | — | — |
| Aug 3, 2023 | Q2 2023 | -$0.11Est: -$0.27 | +59.3% | - | — | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.22Est: -$0.19 | -15.8% | - | — | 10-Q |
| Mar 7, 2023 | Q4 2022 | -$0.14Est: -$0.10 | -40.0% | $458.0KEst: $3.6M | -87.2% | 10-K |